|
1000th Protein Structure Released By Structural Genomics Consortium
The 1000th structure - known as JmjD2C - belongs to a class of proteins involved in epigenetic signalling, a key research area for the SGC. Epigenetics is the study of inherited changes in gene expression caused by proteins such as JmjD2C which 'switch' genes on or off. It is believed that a better understanding of epigenetics could lead to new treatments for a wide variety of diseases including ...
(Sep 30, 2010)
caprotec launches three new caproKits to investigate small molecule–protein interactions
caprotec bioanalytics GmbH announced today the commercial launch of three new caproKits, enabling the discovery, identification and characterization of proteins for applications in functional proteomics and drug development.
(Sep 30, 2010)
Need-to-know news and views for UB faculty and staff
UB Alert: Emergency text, e-mail messages. Sign up > Alexander N. Cartwright, interim vice president for research, has been named acting executive director of UB’s New York State Center of Excellence in Bioinformatics and Life Sciences, Provost Satish K. Tripathi has announced.
(Sep 30, 2010)
Rosetta Genomics Announces Poster Presentations at the AACR's Molecular Diagnostics in Cancer Therapeutics Development ...
REHOVOT, ISRAEL and PHILADELPHIA, PA--(Marketwire - 09/30/10) - Rosetta Genomics, Ltd. (NASDAQ: ROSG - News ), a leading developer and provider of microRNA-based molecular diagnostics, today announced that posters highlighting two of the Company's second generation microRNA-based diagnostic assays were presented by the Company's clinical laboratory director, Dr. Tina B. Edmonston, at the ...
(Sep 30, 2010)
Rosetta Genomics Announces Poster Presentations at the AACR's Molecular Diagnostics in Cancer Therapeutics Development ...
Preliminary Data Presented on Two of the Company's Second Generation MicroRNA-Based Cancer Diagnostic Assays -- miRview(TM) mets2 and miRview(TM) Lung
(Sep 30, 2010)
Proteome Sciences Settles with Sanofi-Aventis for $15M
NEW YORK (GenomeWeb News) – UK proteomics services provider and reagents firm Proteome Sciences today said they have received €11 million ($15 million) from Sanofi-Aventis Deutschland to settle a claim alleging breach of certain warranties.
(Sep 30, 2010)
Consortium solves its 1,000th protein structure
The international Structural Genomics Consortium celebrates its focus on expensive but exciting targets.
(Sep 30, 2010)
New Biomarkers Detect Pancreatic Cancer at an Early Stage
(Ivanhoe Newswire) -- Researchers have identified biomarkers and protein signatures that are hallmarks of cancer at an early stage using aptamer-based proteomics array technology. This novel technology would enable better clinical diagnosis for two of the most aggressive and deadly forms of cancer -- pancreatic and mesothelioma. Moreover, it would provide insight into new therapeutic targets ...
(Sep 30, 2010)
Major disease-vector mosquito reveals the secrets of its immune system
( Swiss Institute of Bioinoformatics ) The Culex quinquefasciatus mosquito poses a significant threat to human health as a blood-sucking transmitter of elephantiasis-causing worms and encephalitis-inducing viruses. An international team of scientists, including researchers from the University of Geneva and the SIB Swiss Institute of Bioinformatics sequenced its genome and studied its responses ...
(Sep 30, 2010)
GeneBio, Berlin Institute of Toxicology Partner to Create LC-MS/MS Spectra Library
NEW YORK (GenomeWeb News) – The Institute of Toxicology in the Clinical Toxicology and Poison Information Centre Berlin is collaborating with Geneva Bioinformatics for use of its SmileMS software to create a library of LC-MS/MS spectra.
(Sep 30, 2010)
Rostock Group of Moscow Opens New Genomics Research Center
NEW YORK (GenomeWeb News) – Moscow-based global investment firm Rostock Group said it has opened a new genomics research center that will carry out wide-scale genetic research in the area of neurodegenerative human diseases.
(Sep 30, 2010)
Akonni's $3M Grant Latest in String of NIH Awards for PCR Array-Based Infectious Disease Dxs
Akonni Biosystems said this week that it has received an approximately $3 million Challenge Grant from the National Institutes of Health to further develop a test for multi-drug-resistant and extensively drug-resistant tuberculosis on its TruDrop gel-drop PCR microarray biochip technology.
(Sep 30, 2010)
|
